Shree Ganesh Remedies share news, announcements and annual reports
NSE: SGRLBSE: 540737Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹639.75.
30 Oct: open ₹639.75, high ₹651.85, low ₹610.00
- Next results date: the board meets on 31 Oct 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹792 Cr1,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 51.34
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.86
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,62259.3% delivered
Shree Ganesh Remedies board meetings
119 filed, newest first. Page 1 of 3.
Oct 2026
27 Oct · Board meeting
Meeting on 31 Oct 2026: quarterly results3 Oct · Board meeting
Aug 2026
10 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
May 2026
11 May · Board meeting
Meeting on 14 May 2026: audited results and quarterly results
Jan 2026
16 Jan · Board meeting
Meeting on 23 Jan 2026: quarterly results16 Jan · Board meeting
Meeting on 16 Jan 202616 Jan · Board meeting
Nov 2025
3 Nov · Board meeting
Meeting on 7 Nov 2025: quarterly results
Sep 2025
15 Sep · Board meeting
Aug 2025
8 Aug · Board meeting
Jul 2025
28 Jul · Board meeting
Meeting on 1 Aug 2025: quarterly results
May 2025
19 May · Board meeting
12 May · Board meeting
Meeting on 19 May 2025: audited results
Jan 2025
29 Jan · Board meeting
Meeting on 5 Feb 2025: quarterly results
Oct 2024
24 Oct · Board meeting
Meeting on 29 Oct 2024: quarterly results
Sep 2024
28 Sep · Board meeting
20 Sep · Board meeting
Meeting on 28 Sep 2024
Aug 2024
30 Aug · Board meeting
12 Aug · Board meeting
5 Aug · Board meeting
Meeting on 12 Aug 2024: quarterly results
Jun 2024
1 Jun · Board meeting
May 2024
31 May · Board meeting
Meeting on 1 Jun 2024: audited results30 May · Board meeting
22 May · Board meeting
Meeting on 30 May 2024: audited results
Mar 2024
16 Mar · Board meeting
15 Mar · Board meeting
Feb 2024
12 Feb · Board meeting
8 Feb · Board meeting
Meeting on 8 Feb 20248 Feb · Board meeting
7 Feb · Board meeting
Meeting on 7 Feb 20247 Feb · Board meeting
5 Feb · Board meeting
Meeting on 12 Feb 2024: quarterly results2 Feb · Board meeting
Meeting on 2 Feb 20242 Feb · Board meeting
Jan 2024
25 Jan · Board meeting
19 Jan · Board meeting
Meeting on 25 Jan 2024: rights issue